_256_384.jpg)
News | May 04, 2022
Eris Lifesciences acquires Oaknet Healthcare for Rs 650 crore
The deal will be financed by Rs 300 crore of internal accruals and Rs 350 crore of borrowings
The deal will be financed by Rs 300 crore of internal accruals and Rs 350 crore of borrowings
Foundation S will incorporate as its cornerstone initiative the former Sanofi Espoir Foundation’s ‘My Child Matters’ program in childhood cancer
As a global mushroom biotechnology group, Mycelium Biotechnology is engaged in mushroom growing, global distribution and offering biotechnology and nutraceutical solutions through global partners
The planned Phase 1 study is a double-blind, randomized, placebo-controlled dose-escalation study in healthy adult subjects and AD patients
Flagship U.S. facility will include biologic manufacturing and late stage research and clinical development of innovative cancer medicines
The plant is expected to start commercial operations from Q4FY24
These bulk orders will contribute to the topline of the company as well as help in improving EBITDA of the company
Covaxin was earlier approved for children 12-18 years of age
Desidustat is currently approved only in India as OxemiaTM for patients with CKD induced anemia
The proposed life sciences research and development centre in North of England region of UK will support acceleration of the company’s research in the areas of biotechnology, health and life sciences
Subscribe To Our Newsletter & Stay Updated
